Barbara Leyman

Insider Reports History

Entity
Individual
Location
C/O Sutro Biopharma, Inc., 111 Oyster Point Boulevard, South San Francisco, CA
Signature
/s/ Edward C. Albini as attorney-in-fact for Barbara Leyman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Barbara Leyman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUTRO BIOPHARMA, INC. Chief Business Dev. Officer Restricted Stock Units (RSUs) 100K $374K $3.74 Jul 8, 2024 Direct
SUTRO BIOPHARMA, INC. Chief Business Dev. Officer Stock Option (Right to Buy Common Stock) 125K Jul 8, 2024 Direct

Insider Reports Filed by Barbara Leyman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STRO SUTRO BIOPHARMA, INC. Jul 8, 2024 2 $0 4 Jul 10, 2024 Chief Business Dev. Officer
STRO SUTRO BIOPHARMA, INC. Jul 8, 2024 0 $0 3 Jul 10, 2024 Chief Business Dev. Officer